Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Aberer, W; Altrichter, S; Cerpes, U; Hawranek, T; Schöffl, C; Kinaciyan, T.
[Hereditary angioedema due to C1-inhibitor deficiency, a national disease management programme].
Wien Klin Wochenschr. 2023; 135(Suppl 8): 785-798.
Doi: 10.1007/s00508-023-02298-x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Aberer Werner
- Co-Autor*innen der Med Uni Graz
- Cerpes Urban
- Schöffl Clemens
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Hereditary angioedema (HAE) is a rare, painful, disabling and potentially fatal disease, where early diagnosis and effective treatment are critical. These Austrian guidelines for the diagnosis and management of HAE provide instructions and advice on the state of the art management of HAE in Austria in contrast to global guidelines, where the situation of all countries worldwide must be taken into account. Our goal is to help Austrian physicians to consider HAE as a differential diagnosis with corresponding symptoms, to make rational decisions for the diagnosis and management of HAE with C1-inhibitor deficiency (type 1 or type 2). The guidelines provide information on common and important clinical symptoms, diagnostic methods, treatment modalities, available HAE-specific medications in Austria and last but not least to motivate physicians to refer patients to HAE centers for confirmation of the diagnosis and adequate treatment decisions.
- Find related publications in this database (Keywords)
- Quinke edema
- Swelling
- Longterm prophylaxis
- Orphan disease
- Quality of life